Clinicopathologic Characteristics of Late Acute Antibody-mediated Rejection in Pediatric Liver Transplantation
暂无分享,去创建一个
D. Parham | Larry L. Wang | J. Emamaullee | Shengmei Zhou | Y. Genyk | M. Warren | Nick Shillingford | Nishant Tiwari | C. Weaver | T. Mitsinikos | Daniel Thomas | Julie Huss Bawab | Carly Weaver | Mikako Warren
[1] Hao-dong Xu,et al. Immunostaining Patterns of Posttransplant Liver Biopsies Using 2 Anti-C4d Antibodies. , 2020 .
[2] Jinson J. Erinjeri,et al. Society of pediatric liver transplantation: Current registry status 2011‐2018 , 2020, Pediatric transplantation.
[3] T. Schiano,et al. Recurrent Idiopathic Liver Allograft Failure. , 2019, American journal of clinical pathology.
[4] A. Israni,et al. OPTN/SRTR 2016 Annual Data Report: Liver , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] N. Kamar,et al. Histological long‐term outcomes from acute antibody‐mediated rejection following ABO‐compatible liver transplantation , 2017, Journal of gastroenterology and hepatology.
[6] B. Naini,et al. Acute antibody‐mediated rejection in ABO‐compatible pediatric liver transplant recipients: case series and review of the literature , 2017, Pediatric transplantation.
[7] E. Furth,et al. 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody‐Mediated Rejection , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[8] M. L. de la Mata,et al. Biopsy‐proven acute cellular rejection as an efficacy endpoint of randomized trials in liver transplantation: a systematic review and critical appraisal , 2016, Transplant international : official journal of the European Society for Organ Transplantation.
[9] I. Bilbao,et al. Acute Antibody-Mediated Rejection as Cause of Late Liver Allograft Failure: A Case Report. , 2015, Transplantation proceedings.
[10] B. Nashan,et al. Long-term Clinical Relevance of De Novo Donor-Specific Antibodies After Pediatric Liver Transplantation , 2015, Transplantation.
[11] E. Reed,et al. Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation , 2015, Transplantation.
[12] A. Demetris,et al. ABO-compatible liver allograft antibody-mediated rejection: an update , 2015, Current opinion in organ transplantation.
[13] L. D’Albuquerque,et al. Quantification of C4d deposition and hepatitis C virus RNA in tissue in cases of graft rejection and hepatitis C recurrence after liver transplantation , 2015, Memorias do Instituto Oswaldo Cruz.
[14] G. Klintmalm,et al. Acute liver allograft antibody‐mediated rejection: An inter‐institutional study of significant histopathological features , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[15] L. Rostaing,et al. Prevalence, Incidence and Risk Factors for Donor‐Specific Anti‐HLA Antibodies in Maintenance Liver Transplant Patients , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[16] I. Jankowska,et al. Antibody-mediated rejection in pediatric liver transplant recipients. , 2014, Annals of transplantation.
[17] S. Uemoto,et al. Application of complement component 4d immunohistochemistry to ABO‐compatible and ABO‐incompatible liver transplantation , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[18] G. Klintmalm,et al. De Novo Donor‐Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[19] G. Klintmalm,et al. Bortezomib for Acute Antibody‐Mediated Rejection in Liver Transplantation , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[20] S. Hübscher. Antibody-mediated rejection in the liver allograft , 2012, Current opinion in organ transplantation.
[21] W-C Lee,et al. Bortezomib is effective to treat acute humoral rejection after liver transplantation. , 2012, Transplantation proceedings.
[22] A. Ormsby,et al. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection. , 2012, Transplant immunology.
[23] Tse-Ching Chen,et al. Clinical perspective of acute humoral rejection after blood type-compatible liver transplantation. , 2011, Transplantation.
[24] S. Hübscher,et al. Late humoral rejection in a compliant ABO-compatible liver transplant recipient. , 2006, Transplantation.